Fragile X Syndrome clinical trials
12 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders
- Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)
- Physical Activity and Community EmPOWERment Project
- Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders
- Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG-Preschool Age
- Speech-in-noise Perception in Autism and Fragile X
- Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG- Infant
- Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome
- Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities
- Parent and Infant Inter(X)Action Intervention (PIXI)
- Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)
- Early Check: Expanded Screening in Newborns
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Fragile X Syndrome” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.